OTUD6B, or OTU Deubiquitinase 6B, is a protein that in humans is encoded by the OTUD6B gene. It belongs to the OTU (ovarian tumor) family of deubiquitinating enzymes, which are involved in the removal of ubiquitin chains from target proteins.Ubiquitination is a post-translational modification where ubiquitin, a small protein, is attached to other proteins. This process regulates various aspects of protein function, including degradation, localization, and activity. Deubiquitinating enzymes like OTUD6B reverse this process, removing ubiquitin from proteins.
OTUD6B, therefore, plays a crucial role in maintaining the balance of protein ubiquitination within the cell. By removing ubiquitin from target proteins, it can influence their stability, localization, and function. This can have downstream effects on various cellular processes, including cell growth, signal transduction, and response to stress.Mutations in the OTUD6B gene have been associated with a rare autosomal recessive congenital disorder known as OTUD6B syndrome. This disorder is characterized by intellectual disability, heart defects, short stature, and skeletal abnormalities. It is believed that these mutations disrupt the deubiquitinase activity of OTUD6B, leading to dysregulation of ubiquitin-dependent processes.However, the specific substrates and physiological roles of OTUD6B are not fully understood, and more research is needed to fully elucidate its function and the mechanisms by which it contributes to disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, another proteasome inhibitor, might indirectly affect OTUD6B function by altering protein ubiquitination dynamics. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41, a ubiquitin-activating enzyme inhibitor, can indirectly influence OTUD6B by affecting ubiquitination processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, a compound in turmeric, affects multiple signaling pathways and might have an indirect impact on OTUD6B. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG, a catechin found in green tea, can influence various signaling pathways, potentially modulating OTUD6B activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels, which may indirectly influence OTUD6B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, affects various cellular processes, potentially influencing OTUD6B activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, can affect gene expression, potentially impacting OTUD6B activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, found in grapes, can modulate various cellular processes potentially influencing OTUD6B activity. | ||||||